BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30097865)

  • 21. ADP-ribosylation: new facets of an ancient modification.
    Palazzo L; Mikoč A; Ahel I
    FEBS J; 2017 Sep; 284(18):2932-2946. PubMed ID: 28383827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease.
    Lüscher B; Bütepage M; Eckei L; Krieg S; Verheugd P; Shilton BH
    Chem Rev; 2018 Feb; 118(3):1092-1136. PubMed ID: 29172462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADP-Ribosylation Post-Translational Modification: An Overview with a Focus on RNA Biology and New Pharmacological Perspectives.
    Manco G; Lacerra G; Porzio E; Catara G
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TCDD-inducible poly-ADP-ribose polymerase (TIPARP/PARP7) mono-ADP-ribosylates and co-activates liver X receptors.
    Bindesbøll C; Tan S; Bott D; Cho T; Tamblyn L; MacPherson L; Grønning-Wang L; Nebb HI; Matthews J
    Biochem J; 2016 Apr; 473(7):899-910. PubMed ID: 26814197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life.
    Perina D; Mikoč A; Ahel J; Ćetković H; Žaja R; Ahel I
    DNA Repair (Amst); 2014 Nov; 23():4-16. PubMed ID: 24865146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biallelic
    Beijer D; Agnew T; Rack JGM; Prokhorova E; Deconinck T; Ceulemans B; Peric S; Milic Rasic V; De Jonghe P; Ahel I; Baets J
    Life Sci Alliance; 2021 Nov; 4(11):. PubMed ID: 34479984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ADP-ribosyltransferases, an update on function and nomenclature.
    Lüscher B; Ahel I; Altmeyer M; Ashworth A; Bai P; Chang P; Cohen M; Corda D; Dantzer F; Daugherty MD; Dawson TM; Dawson VL; Deindl S; Fehr AR; Feijs KLH; Filippov DV; Gagné JP; Grimaldi G; Guettler S; Hoch NC; Hottiger MO; Korn P; Kraus WL; Ladurner A; Lehtiö L; Leung AKL; Lord CJ; Mangerich A; Matic I; Matthews J; Moldovan GL; Moss J; Natoli G; Nielsen ML; Niepel M; Nolte F; Pascal J; Paschal BM; Pawłowski K; Poirier GG; Smith S; Timinszky G; Wang ZQ; Yélamos J; Yu X; Zaja R; Ziegler M
    FEBS J; 2022 Dec; 289(23):7399-7410. PubMed ID: 34323016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADP-ribosylation: An emerging direction for disease treatment.
    Liu YT; Che Y; Qiu HL; Xia HX; Feng YZ; Deng JY; Yuan Y; Tang QZ
    Ageing Res Rev; 2024 Feb; 94():102176. PubMed ID: 38141734
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A role of intracellular mono-ADP-ribosylation in cancer biology.
    Scarpa ES; Fabrizio G; Di Girolamo M
    FEBS J; 2013 Aug; 280(15):3551-62. PubMed ID: 23590234
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Promise of Proteomics for the Study of ADP-Ribosylation.
    Daniels CM; Ong SE; Leung AK
    Mol Cell; 2015 Jun; 58(6):911-24. PubMed ID: 26091340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly (ADP-ribose) polymerase1 regulates growth and multicellularity in D. discoideum.
    Jubin T; Kadam A; Saran S; Begum R
    Differentiation; 2016; 92(1-2):10-23. PubMed ID: 27021638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. When PARPs Meet Antiviral Innate Immunity.
    Zhu H; Zheng C
    Trends Microbiol; 2021 Sep; 29(9):776-778. PubMed ID: 33483164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into the biogenesis, function, and regulation of ADP-ribosylation.
    Cohen MS; Chang P
    Nat Chem Biol; 2018 Feb; 14(3):236-243. PubMed ID: 29443986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of ADP-Ribosylating Bacterial Toxins.
    Chen C; Barbieri JT
    Methods Mol Biol; 2018; 1813():287-295. PubMed ID: 30097876
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying Target RNAs of PARPs.
    Bock FJ; Chang P
    Methods Mol Biol; 2018; 1813():327-341. PubMed ID: 30097879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linking DNA repair and cell cycle progression through serine ADP-ribosylation of histones.
    Brustel J; Muramoto T; Fumimoto K; Ellins J; Pears CJ; Lakin ND
    Nat Commun; 2022 Jan; 13(1):185. PubMed ID: 35027540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of PARPs and ADP-ribosylation on inflammation and host-pathogen interactions.
    Fehr AR; Singh SA; Kerr CM; Mukai S; Higashi H; Aikawa M
    Genes Dev; 2020 Mar; 34(5-6):341-359. PubMed ID: 32029454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular basis for the reversible ADP-ribosylation of guanosine bases.
    Schuller M; Raggiaschi R; Mikolcevic P; Rack JGM; Ariza A; Zhang Y; Ledermann R; Tang C; Mikoc A; Ahel I
    Mol Cell; 2023 Jul; 83(13):2303-2315.e6. PubMed ID: 37390817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Determination of MAR Hydrolase Residue Specificity In Vitro by Tandem Mass Spectrometry.
    McPherson RL; Ong SE; Leung AKL
    Methods Mol Biol; 2018; 1813():271-283. PubMed ID: 30097875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADP-ribosyltransferases and poly ADP-ribosylation.
    Liu C; Yu X
    Curr Protein Pept Sci; 2015; 16(6):491-501. PubMed ID: 25938242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.